Header Logo

Connection

RADEK SKODA to Mitoxantrone

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Mitoxantrone.
RADEK SKODA
Connection Strength
0.025
Mitoxantrone
  1. JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematol. 2013; 129(1):23-5.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.